Artiva Biotherapeutics CEO Fred Aslan sells $168,875 in common stock

PUBT · 5d ago
Artiva Biotherapeutics CEO Fred Aslan sells $168,875 in common stock
  • Artiva Biotherapeutics CEO Fred Aslan sold 23,463 common shares on Oct. 6, 2026.
  • Weighted average sale price USD 7.1977 per share.
  • Direct holdings fell to 1,519,606 shares following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-416953), on October 07, 2026, and is solely responsible for the information contained therein.